The 5th International mRNA Health Conference to Showcase Tremendous Advances in the Development of mRNA Drugs

Monday, July 31, 2017 Genetics & Stem Cells News
Email Print This Page Comment bookmark
Font : A-A+

Global Thought Leaders Convene to Share Progress in Research and Development of mRNA Products Believed to be the Next Evolution in Human Medicine

TÜBINGEN, Germany and BERLIN, July 31, 2017 /PRNewswire/ -- The 5th International

mRNA Health Conference, taking place on November 1-2 in Berlin, Germany, is the premier meeting destination for professionals and academia in the field of mRNA drugs. In its fifth year, the conference is returning to Berlin to celebrate the remarkable research, preclinical and clinical progress of the past year. The event will provide participants an opportunity to attend scientific presentations given by the most esteemed experts in the field, secure updates on advances in mRNA technology, and to network with colleagues.

Hundreds of world renowned innovators, scientists, academia and pharmaceutical delegates are expected to attend the conference as mRNA therapeutic technology evolves from scientific concept to medical application. Approximately 25 speakers will present on preclinical and clinical development in the fields of oncology, infectious diseases and molecular therapies as well as mRNA delivery, design and product development. Additionally, a poster session will provide research groups and company representatives the opportunity to showcase their data to attendees.

Ingmar Hoerr, Ph.D., founding member of the International mRNA Health Conference and CEO of CureVac, commented, "The mRNA industry has witnessed a multitude of transformational events over the past twelve months, with multiple programs being pushed through the clinic and companies developing infrastructure to prepare for eventual commercialization efforts. It seems that every year since our colleagues from Moderna, BioNTech and we began hosting this meeting, we grow substantially closer to realizing mRNA as an actual medical application. Academics and industry continue to break new ground in understanding the vast potential of the technology across multiple therapeutic fields. With the conference entering its fifth year, we are delighted to welcome our colleagues in the field to celebrate another successful year of mRNA research and development as we bring our vision closer to realization."

The 5th International mRNA Health Conference

Date: November 1-2, 2017

Place: Berlin, Germany

Location: Sofitel Berlin Kurfürstendamm, Augsburger Strasse 41, 10789 Berlin, Germany


Program: The Conference will provide a comprehensive program around the medical use of Messenger RNA. The Science Committee of the Conference with members from three leading mRNA companies, BioNTech, CureVac and Moderna Therapeutics, is calling for abstracts for a potential talk or poster presentation during the conference – see

Registration: Register by September 15th and benefit from early bird prices under


Media Contacts

Verena Lauterbach, Senior Manager CommunicationsCureVac AG, Tübingen, GermanyT: +49 (0) 7071 9883

Jason Rando, EVP & COOTiberend Strategic Advisors, New York+1 212 375


View original content:

SOURCE International mRNA Health Conference

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store